Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myo-inositol vs Antioxidants vs Surgery Alone Post Varicocelectomy in Infertile Men
NCT07915388Phase 3Not yet recruiting
- Sponsor
- Fayoum University Hospital
- Start
- Oct 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of myo-inositol in infertility (3 arms), sponsored by Fayoum University Hospital. Primary endpoints: Semen analysis sperm concentration at 6 months, Semen analysis sperm motility at 6 months and 1 more. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
myo-inositol
03
Conditions
infertility
Beyond the preview
Go deeper on NCT07915388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07915388.